A preventive vaccine for gonorrhea would be a major advance in public health.

Monday, May 13, 2024 Exploring a Meningitis Vaccine for Gonorrhea Prevention Scanning electron micrograph of Neisseria gonorrhoeae bacteria, which causes gonorrhea. Credit: NIAID A preventive vaccine for gonorrhea would be a major advance in public health, according to an editorial co-authored by NIAID Director Jeanne Marrazzo and Myron Cohen of the University of North Carolina at Chapel Hill. The genetic sequences of the bacteria that cause gonorrhea and meningitis B are closely related. This has led researchers to explore whether the 4CMenB vaccine, approved by the Food and Drug Administration for meningitis B, might also prevent gonorrhea. NIAID is sponsoring an efficacy study of the 4CMenB vaccine for gonorrhea prevention in Malawi, Thailand, and the United States. Learn More National Institute of Allergy and Infectious Diseases  |  National Institutes of Health

---

Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help.

This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).

                           

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107